Overview on Therapeutic Drug Monitoring Market - Global Manufacturers, Industry Size, Applications, Opportunity and Forecast
Personalized medicine is driving the growth of therapeutic drug monitoring market, owing to increasing demand for better treatment outcome with minimum side effects from the medication. For instance, TDM is majorly used for anti-cancer drugs monitoring fo
(EMAILWIRE.COM, January 24, 2019 ) Technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the market. Adjunct technologies such as biomarker identification using proteomics to accurately identify clinical outcomes and genetic testing are expected to benefit the growth of the therapeutic drug monitoring market.
#Access Sample Study Papers on Therapeutic Drug Monitoring Market
Now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=518327 .
Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).
Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data Sources From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.2.1 Key Industry Insights
Executive Summary
Premium Insights
4.1 Therapeutic Drug Monitoring (TDM): Market Overview
4.2 Asia Pacific: Therapeutic Drug Monitoring Market, By Class of Drug
4.3 Geographic Mix: Therapeutic Drug Monitoring Market
4.4 Therapeutic Drug Monitoring Market, By End User
Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Use of TDM in Traditional Anticancer Therapies
5.2.1.2 Rising Number of Organ Transplant Procedures
5.2.2 Restraints
5.2.2.1 Reluctance of Small Hospitals to Offer TDM Services
5.2.3 Opportunities
5.2.3.1 Monitoring of Biosimilars in Autoimmune Diseases
5.2.4 Challenges
5.2.4.1 Operational Barriers Faced in Conducting TDM Tests
The therapeutic drug monitoring market is projected to reach USD 2.55 billion by 2020 from USD 1.78 billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).
In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region.
Get More Information on Therapeutics Drug Monitoring Market with Top Trends and Company Profiles at https://www.openpr.com/news/1475241/Growth-of-Therapeutic-Drug-Monitoring-Market-Exceeded-to-US-2-55-Billion-in-Coming-Years-Report-on-Industry-Trends-and-Key-Players.html .
The growth of therapeutic drug monitoring market. Advancement in tools for TDM such as assay kits, chromatography columns, spectrometry, and alternative matrices such as interstitial fluid provide continuous real time monitoring of the therapeutic drug through Probe Scientific’s new MicroEye Technology. The therapeutic drug monitoring market is divided into hospital laboratories, commercial/private laboratories, and other end users. Hospital laboratories is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories as they have the appropriate equipment as well as skilled staff to deliver clinically meaningful interpretations from TDM assays.
#Flat Discount on “Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020” research @ http://www.reportsnreports.com/contacts/discount.aspx?name=518327 .
North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure.
Therapeutic drugs monitor market, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are major drivers for therapeutic drug monitoring market. Adjunct technologies like biomarker identification using proteomics to accurately identify clinical outcome & genetic testing are expected to benefit growth of market.
#Access Sample Study Papers on Therapeutic Drug Monitoring Market
Now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=518327 .
Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).
Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data Sources From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.2.1 Key Industry Insights
Executive Summary
Premium Insights
4.1 Therapeutic Drug Monitoring (TDM): Market Overview
4.2 Asia Pacific: Therapeutic Drug Monitoring Market, By Class of Drug
4.3 Geographic Mix: Therapeutic Drug Monitoring Market
4.4 Therapeutic Drug Monitoring Market, By End User
Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Use of TDM in Traditional Anticancer Therapies
5.2.1.2 Rising Number of Organ Transplant Procedures
5.2.2 Restraints
5.2.2.1 Reluctance of Small Hospitals to Offer TDM Services
5.2.3 Opportunities
5.2.3.1 Monitoring of Biosimilars in Autoimmune Diseases
5.2.4 Challenges
5.2.4.1 Operational Barriers Faced in Conducting TDM Tests
The therapeutic drug monitoring market is projected to reach USD 2.55 billion by 2020 from USD 1.78 billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).
In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region.
Get More Information on Therapeutics Drug Monitoring Market with Top Trends and Company Profiles at https://www.openpr.com/news/1475241/Growth-of-Therapeutic-Drug-Monitoring-Market-Exceeded-to-US-2-55-Billion-in-Coming-Years-Report-on-Industry-Trends-and-Key-Players.html .
The growth of therapeutic drug monitoring market. Advancement in tools for TDM such as assay kits, chromatography columns, spectrometry, and alternative matrices such as interstitial fluid provide continuous real time monitoring of the therapeutic drug through Probe Scientific’s new MicroEye Technology. The therapeutic drug monitoring market is divided into hospital laboratories, commercial/private laboratories, and other end users. Hospital laboratories is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories as they have the appropriate equipment as well as skilled staff to deliver clinically meaningful interpretations from TDM assays.
#Flat Discount on “Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020” research @ http://www.reportsnreports.com/contacts/discount.aspx?name=518327 .
North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure.
Therapeutic drugs monitor market, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are major drivers for therapeutic drug monitoring market. Adjunct technologies like biomarker identification using proteomics to accurately identify clinical outcome & genetic testing are expected to benefit growth of market.
Contact Information:
ReportsnReports
Snehal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Snehal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results